Aetna modified CPB 0376 covering SPECT imaging, effective February 25, 2026. Here's what billing teams need to know.
Aetna, a CVS Health company, updated its SPECT coverage policy under CPB 0376 Aetna system, affecting CPT codes 78071, 78072, 78451, 78452, 78803, 78830, 78831, and 78832, along with HCPCS code A9584 for Ioflupane I-123. The policy governs both cardiac and non-cardiac SPECT indications and routes cardiac imaging criteria through eviCore Healthcare — a detail that has real teeth for reimbursement if your team misses it.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna |
| Policy | Single Photon Emission Computed Tomography (SPECT) |
| Policy Code | CPB 0376 |
| Change Type | Modified |
| Effective Date | February 25, 2026 |
| Impact Level | High |
| Specialties Affected | Nuclear medicine, cardiology, neurology, oncology, endocrinology, orthopedics, pulmonology |
| Key Action | Audit precertification requirements by CPT code and confirm cardiac SPECT claims align with eviCore cardiac imaging guidelines before submitting |
Aetna SPECT Coverage Criteria and Medical Necessity Requirements 2026
The Aetna SPECT coverage policy under CPB 0376 splits into two tracks: non-cardiac and cardiac. Each track has different criteria and different gatekeepers. Treating them the same is how you generate a claim denial.
Non-Cardiac SPECT
Aetna considers SPECT medically necessary for 14 specific non-cardiac indications. These are not suggestions — they're the criteria list. If the patient's diagnosis doesn't map to one of these, you don't have medical necessity under this policy.
The covered non-cardiac indications include: osteomyelitis assessment to distinguish bone from soft tissue infection; spondylolysis and stress fractures not visible on x-ray; liver hemangioma diagnosis; pulmonary embolism diagnosis via SPECT ventilation/perfusion scintigraphy; brain tumor differentiation from necrotic tissue; Parkinson's disease versus essential tremor distinction using DaTSCAN (Ioflupane I-123, billed as HCPCS A9584); fever of unknown origin after initial workup fails; parathyroid imaging in parathyroid disease; liver metastases or primary liver tumors before and after hepatic artery chemotherapy or chemoembolization; abscess localization for suspected infection or inflammatory process; lymphoma (tumor vs. necrosis distinction); neuroendocrine tumor diagnosis and staging; pre-surgical ictal seizure focus detection in epilepsy (as a PET substitute); and thyroid cancer iodine imaging for initial and subsequent staging.
SPECT-CT fusion — billed under CPT 78072 — carries its own, narrower criteria. Aetna covers it only for parathyroid imaging when the patient has an enlarged parathyroid gland, parathyroid hyperplasia, or suspected parathyroid adenoma or carcinoma, AND laboratory evidence of hyperparathyroidism: parathyroid hormone greater than 55 pg/mL and serum calcium greater than 10.2 mg/dL. Both lab thresholds must be met. One without the other won't clear medical necessity for CPT 78072.
Cardiac SPECT
Cardiac SPECT — CPT 78451, 78452, 78453, and 78454 — is covered for diagnosis and prognosis in coronary artery disease, but Aetna delegates the specific criteria to eviCore Healthcare's Cardiac Imaging Clinical Guidelines. This is where billing teams often get tripped up.
You can't apply the same documentation standards you'd use for non-cardiac indications. Pull up the eviCore guidelines directly at evicore.com, select "Aetna" (or Aetna NJ, Aetna NY, or the appropriate Aetna Better Health Medicaid option), and find the Cardiac Imaging Guidelines PDF. No login is required. Search by CPT code for your specific situation.
Prior Authorization
Precertification — the Aetna term for prior authorization — may be required for select SPECT procedures. Use Aetna's CPT code search tool on their precertification lists page to check by code before you schedule. Don't assume your procedure doesn't require prior auth just because it's covered under CPB 0376. That assumption generates denials.
Aetna SPECT Exclusions and Non-Covered Indications
Three codes are explicitly excluded under CPB 0376. These aren't borderline — Aetna considers the indications experimental, investigational, or unproven.
CPT 0331T (myocardial sympathetic innervation imaging, planar) and CPT 0332T (same with tomographic SPECT) are not covered. These are Category III codes, and Aetna is aligned with the general market here — there's limited clinical evidence supporting routine reimbursement.
CPT +0742T (absolute quantitation of myocardial blood flow, SPECT) is also not covered. This add-on code for AQMBF is increasingly discussed in cardiology circles, but Aetna hasn't moved it to covered status under this policy.
Aetna also considers SPECT myocardial perfusion imaging inappropriate — and therefore not covered — when the American College of Cardiology's appropriateness criteria classify the study as "inappropriate." The policy references ACC criteria directly. If you're billing cardiac SPECT for an indication the ACC flags as inappropriate, Aetna will treat that as a non-covered service.
The real issue here: if your cardiologists are ordering SPECT for post-PTCA routine screening without symptoms, that's a high-risk scenario under this policy. Check the ACC criteria and the eviCore guidelines before you bill.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Osteomyelitis assessment (bone vs. soft tissue) | Covered | 78803, 78830, 78831, 78832 | Must meet medical necessity criteria |
| Spondylolysis / stress fractures not visible on x-ray | Covered | 78803, 78830, 78831, 78832 | X-ray must have been performed first |
| Liver hemangioma diagnosis | Covered | 78803, 78830, 78831, 78832 | — |
| Pulmonary embolism (SPECT V/Q scintigraphy) | Covered | 78803, 78830, 78831, 78832 | SPECT V/Q specifically required |
| Brain tumor vs. necrosis differentiation | Covered | 78803, 78830, 78831, 78832 | — |
| Parkinson's vs. essential tremor (DaTSCAN) | Covered | 78803, A9584 | HCPCS A9584 for Ioflupane I-123 |
| Fever of unknown origin (after failed initial workup) | Covered | 78803, 78830, 78831, 78832 | Initial studies including physical exam must have failed |
| Parathyroid imaging — planar with SPECT | Covered | 78071 | Parathyroid disease diagnosis |
| Parathyroid imaging — SPECT-CT fusion | Covered | 78072 | PTH >55 pg/mL AND serum calcium >10.2 mg/dL required |
| Liver metastases / primary tumors (before/after hepatic artery chemo) | Covered | 78803, 78830, 78831, 78832 | — |
| Abscess localization | Covered | 78803, 78830, 78831, 78832 | Suspected or known localized infection/inflammation |
| Lymphoma (tumor vs. necrosis) | Covered | 78803, 78830, 78831, 78832 | — |
| Neuroendocrine tumors (diagnosis and staging) | Covered | 78803, 78830, 78831, 78832 | — |
| Pre-surgical seizure focus detection in epilepsy | Covered | 78803, 78830, 78831, 78832 | Used in place of PET (78608/78609) |
| Thyroid cancer iodine imaging | Covered | 78803, 78830, 78831, 78832 | Initial and subsequent staging |
| Coronary artery disease — diagnosis and prognosis | Covered (with criteria) | 78451, 78452, 78453, 78454 | Must meet eviCore Cardiac Imaging Guidelines |
| Myocardial infarct avid imaging | Covered (with criteria) | 78469 | Must meet eviCore criteria |
| Myocardial sympathetic innervation imaging | Not Covered | 0331T, 0332T | Experimental/investigational |
| Absolute quantitation of myocardial blood flow (AQMBF) | Not Covered | +0742T | Experimental/investigational |
| Post-PTCA routine SPECT (no symptoms) | Not Covered | 78451, 78452 | ACC "inappropriate" designation applies |
Aetna SPECT Billing Guidelines and Action Items 2026
These are the steps your billing team needs to take now — not after you see your first denial.
| # | Action Item |
|---|---|
| 1 | Check precertification requirements for every SPECT code you bill before February 25, 2026. Use Aetna's CPT code search tool on their precertification page. The policy flags select procedures as requiring precertification but doesn't list them in the CPB itself. You need to verify by code, not by assumption. |
| 2 | Separate your cardiac and non-cardiac SPECT workflows. Non-cardiac SPECT claims should be documented against the 14 CPB 0376 indications. Cardiac SPECT claims — especially CPT 78451 and 78452 — must align with eviCore's Cardiac Imaging Guidelines. Different criteria, different supporting documentation, different denial risk. |
| 3 | Flag CPT 78072 claims for dual lab value documentation. If your team bills SPECT-CT fusion for parathyroid imaging, your medical records must show PTH greater than 55 pg/mL and serum calcium greater than 10.2 mg/dL. One value is not enough. Build this into your pre-claim checklist now. |
| 4 | Remove CPT 0331T, 0332T, and +0742T from your Aetna charge capture. These codes are not covered under CPB 0376 Aetna system. If they're still in your charge master for Aetna patients, you're generating guaranteed denials. Pull them now. |
| 5 | Confirm DaTSCAN documentation links to Parkinson's vs. essential tremor distinction. When billing A9584 with SPECT, your documentation needs to clearly support that indication. "Tremor, unspecified" won't carry the claim. |
| 6 | Pull the eviCore Cardiac Imaging Guidelines now and distribute them to your cardiology billing staff. eviCore updates these guidelines annually and reserves the right to change them without prior notice — though draft guidelines are posted 90 days before implementation. Make it someone's job to monitor that page. |
| 7 | If your cardiac SPECT volume is high, loop in your compliance officer. The ACC appropriateness criteria exclusion is real exposure. If your practice bills significant cardiac SPECT, a targeted audit against ACC criteria before the effective date of February 25, 2026 is worth the time. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for SPECT Under CPB 0376
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 78071 | CPT | Parathyroid planar imaging (including subtraction, when performed); with tomographic (SPECT) |
| 78072 | CPT | Parathyroid planar imaging (including subtraction, when performed); with tomographic (SPECT) and concurrently acquired CT |
| 78451 | CPT | Myocardial perfusion imaging, tomographic (SPECT) — including attenuation correction, qualitative or quantitative wall motion, ejection fraction |
| 78452 | CPT | Myocardial perfusion imaging, tomographic (SPECT) — multiple studies, at rest and/or stress and/or redistribution |
| 78453 | CPT | Myocardial perfusion imaging, planar — including qualitative or quantitative wall motion, ejection fraction |
| 78454 | CPT | Myocardial perfusion imaging, planar — multiple studies, at rest and/or stress and/or redistribution |
| 78469 | CPT | Myocardial imaging, infarct avid, planar; tomographic SPECT with or without quantification |
| 78803 | CPT | Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical — tomographic (SPECT) |
| 78830 | CPT | Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical — tomographic (SPECT), single area |
| 78831 | CPT | Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical — tomographic (SPECT), minimum 2 areas |
| 78832 | CPT | Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical — tomographic (SPECT) with concurrently acquired CT |
Not Covered / Experimental Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 0331T | CPT | Myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment | Experimental, investigational, or unproven |
| 0332T | CPT | Myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment; with tomographic (SPECT) | Experimental, investigational, or unproven |
| +0742T | CPT | Absolute quantitation of myocardial blood flow (AQMBF), single-photon emission computed tomography (SPECT) | Experimental, investigational, or unproven |
Covered HCPCS Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| A9584 | HCPCS | Iodine I-123 Ioflupane, diagnostic, per study dose, up to 5 millicuries |
Key ICD-10-CM Diagnosis Codes
The full ICD-10 list under CPB 0376 spans 725 codes across oncology, neurology, cardiology, endocrinology, orthopedics, and infectious disease. Below are representative codes from the actual policy data:
| Code | Description |
|---|---|
| C22.0–C22.9 | Malignant neoplasm of liver and intrahepatic bile ducts |
| C25.0–C25.9 | Malignant neoplasm of pancreas (VIPoma, islet cell tumors) |
| C34.0–C34.9x | Malignant neoplasm of bronchus and lung |
The full ICD-10 list is available in the CPB 0376 Aetna policy document. Review it against your patient population to confirm diagnosis code alignment before billing.
Get the Full Picture for CPT 78072
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.